PLAY PODCASTS
COVID-19: Answering the Questions, Part 13
Episode 29

COVID-19: Answering the Questions, Part 13

In Part 13 of this ongoing COVID-19 series, listen to a brief update on monoclonal antibody treatments for COVID-19 and the recently released COVID-19 vaccine efficacy information from Jens D. Lundgren, MD, DMSc.

Decera Clinical Education Infectious Disease Podcast · Jens D. Lundgren MD DMSc

December 8, 202038m 20s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Part 13 of an ongoing series, Jens D. Lundgren, MD, DMSc, provides a brief update monoclonal antibody treatments for COVID-19, including the FDA Emergency Use Authorization for bamlanivimab and discusses the recently released information on COVID-19 vaccine efficacy. After the update, Professor Lundgren answers clinician questions on various aspects of COVID-19. 

Presenter:

Jens D. Lundgren, MD, DMSc
Professor
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3eDoJF0


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

covid-19 new zealandmrna vaccinesars-cov-2 preventioncovid-19 incidencebamlanivimabsevere covid-19sars-cov-2 incidencemoderna vaccinecovid-19 monoclonal antibody treatmentsars-cov-2 transmissioncovid-19 treatmentcovid-19 endemiccovid-19 eliminationpfizer vaccinecovid-19 vaccinecovid-19covid-19 preventionsars-cov-2covid-19 public health